U.S.
October 27, 2014. Bill Saporito, “Hospitals Furious at Cancer-Drug Price Hikes,” Time Magazine.
October 26, 2014. John Fauber, “FDA approves cancer drugs without proof they’re extending lives,” Journal Sentinel.
October 22, 2014. Peter Bach, “Indication-Specific Pricing for Cancer Drugs,” The Journal of the American Medical Association.
October 15, 2014. Benjamin Davies, “Bladder Cancer Drug Shortages and Price Gouging: The New Reality,” Forbes.
October 13, 2014. Julie Appleby, “Got Insurance? You Still May Pay A Steep Price For Prescriptions,” Kaiser Health News.
October 13, 2014. Roxanne Nelson, “Patent-Protected Oral Cancer Drugs Are Drivers of High Costs,” Medscape.
October 11, 2014. Julie Appleby, “Health plans are shifting specialty Rx costs to you,” USA Today.
October 10, 2014. Loren Bonner, “Media puts the spotlight on the high price of cancer drugs,” American Pharmacists Association.
October 7, 2014. Ed Silverman, “‘Financial Toxicity:’ Who’s Really to Blame for High Cancer Drug Prices?” The Wall Street Journal
October 6, 2014. Hester Plumridge, “New Costly Cancer Treatments Face Hurdles Getting to Patients,” The Wall Street Journal.
October 5, 2014. “The “eye popping” cost of cancer drugs,” CBS News.
September 29, 2014. Elise Viebeck, “Study: Cancer costs ‘skyrocketed’ despite drug cuts,” The Hill.
May 7, 2014. Robert Langreth, “Cancer Doctors Join Insurers in U.S. Drug-Cost Revolt,” Bloomberg.
January 4, 2014. “Hard pills to swallow,” The Economist.
December 18, 2013. Richard Besser, “Outrage at the Increasingly High Cost of Cancer Drugs,” ABC News.
November 14, 2013. Tracy Staton, “J&J, Pharmacyclics slap $130,000 price on Imbruvica for rare lymphoma,” FiercePharma.
October 20, 2013. Stephen Hall, “The Cost of Living,” New York Magazine.
May 30, 2013. Hagop Kantarjian, “The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts,” American Society of Hematology: Blood Journal.
May 15, 2013. Brian Till, “How Drug Companies Keep Medicine Out of Reach,” The Atlantic.
May 9, 2013. Alison Rose Levy, “The Sky-High Price of Chemotherapy: Why Do Cancer Drugs Cost So Much?” TakePart.
May 1, 2013. The Editorial Board, “Exorbitant Prices for Leukemia Drugs,” The New York Times.
April 25, 2013. Andrew Pollack, “Doctors Denounce Cancer Drug Prices of $100,000 a Year,” The New York Times.
April 25, 2013. Anna Edney, “Cancer drugs’ high cost out of reach for many patients, doctors say,” The Washington Post.
April 10, 2013. Thomas Bollyky, “Why Chemotherapy That Costs $70,000 in the U.S. Costs $2,500 in India,” The Atlantic.
April 3, 2012. Sarah Kliff, “The cost of cancer care,” The Washington Post.
January 2, 2012. Ezekiel Emanuel and Steven Pearson, “It Costs More, but Is It Worth More?” The New York Times.
October 10, 2011. Michelle Andrews, “Cancer treatment costs can be prohibitive, even with insurance,” The Washington Post.
July 6, 2011. “Extremely Expensive Cancer Drugs,” The New York Times.
May 26, 2011. “The costly war on cancer,” The Economist.
September 6, 2010. Marilynn Marchione, “Provenge, Cancer Drug, Costs $93,000: Sky High Drug Prices Impact Life-Or-Death Decisions,” The Huffington Post.
December 4, 2009. Andrew Pollack, “Questioning a $30,000-a-Month Cancer Drug,” The New York Times.
Canada
November 6, 2014. Carmen Chai, “The cost of cancer: How much do cancer drugs cost Canadians?,” Global News.
June 2011. G. Dranitsaris, “The development of a value based pricing index for new drugs in metastatic colorectal cancer,” European Journal of Cancer.
April 3, 2011. Andre Picard, “The cost of drugs: breaking the bank to stay alive,” The Globe and Mail.
U.K
October 26, 2014. Joe Shute, “Yours for $2 million: Place on cancer drug trial,” The Telegraph.
October 21, 2014. Ben Hirschler, “Petition calls on Roche to cut breast cancer drug price,” Reuters.
October 11, 2014. Stephen Adams and Martyn Halle, “Key cancer drug may be axed for new patients: Thousands could be denied life-extending medicines in money saving move,” The Daily Mail.
September 29, 2014. Laura Donnelly, “Women denied drugs which limit breast cancer risk,” The Telegraph.
September 9, 2014. Ben Adams, “Roche should be ‘shamed’ into lowering cancer drug price,” Pharmafile.
August 8, 2014. “Pressure grows on Roche to lower breast cancer drug price,” NICE.
March 10, 2014. “‘Effective, Life-Prolonging’ Cancer Drug Is Too Expensive For NHS, NICE Says,” The Huffington Post UK.
April 29, 2013. Jeremy Laurance, “The real cancer killer: rip-off prices for drugs set by ‘profiteering’ Big Pharma giants,” The Independent.
November 6, 2012. Nick Triggle, “Cost of cancer in the UK ‘over £15bn’ a year,” BBC.
November 19, 2009. Rebecca Smith, “Drug for terminal liver cancer patients ‘too expensive’,” The Telegraph.
January 14, 2009. Graham Satchell, “Cancer drug victory in the offing,” BBC.
European Union
October 15, 2013. Roxanne Nelson, “Cancer Care Costs Vary Substantially Among EU Nations,” Medscape.
October 14, 2013. Richard Sullivan, “Economic burden of cancer across the European Union: a population-based cost analysis,” Academia.edu
March 2011. Helen Saul, “Time for reform of drug pricing in Europe?” The European Journal of Cancer.
Romania
April 22, 2013. “Romania Starts Cracking Down on Parallel Exports,” Business Review.
January 31, 2013. Liliana Ciobanu, “Romania’s Underground Cancer Drug Networks,” The Atlantic.
August 3, 2012. Ioana Tudor, “Health Ministry Wants To Bring To Romania 34 Cheap Cancer Drugs,” ZF English.
Poland
Janusz Mlynarski, “Ceny leków zabijaj? chorych na raka (Prices of drugs are killing cancer patients),” The Polish Review.
Hungary
July 22, 2014. “Hungary’s OEP releases data on oncology expenditure in 2013, warns of “cost explosion”,” IHS.
Netherlands
June 20, 2014. Ellen Fisher, “KWF Kankerbestrijding: rem op te dure kankermedicijnen (KWF: brakes on expensive cancer drugs),” de Volkskrant.
Greece
February 22, 2014. Anthony Faiola, “Greece’s prescription for a health-care crisis,” The Washington Post.
November 5, 2012. Nikolaj Nielsen, “Merck stops cancer drug supply to Greek hospitals,” EUObserver.
November 3, 2012. “Germans stop shipment of life-saving cancer drug to Greece as Euro crisis deepens,” The Daily Mail.
Spain
February 12, 2014. Steve Tallantyre, “Cancer drug maker wants 4000% Spanish price hike,” The Local.
January 1, 2014. “El precio de los medicamentos contra el cáncer (The price of cancer drugs),” La Nueva Espana.
France
November 5, 2013. Jean-Yves Nau, “La facture immorale des nouveaux médicaments anti-cancer (The Immoral bill of new anti-cancer drugs),” Slate FR.
July 5, 2012. Yves Mamou, “Cancer : le coût des médicaments explose (Cancer drug costs explode),” Le Figaro.
March 9, 2011. Anne Jeanblanc, “Le traitement du cancer coûte-t-il trop cher? (Cancer treatment costs are too expensive),” Le Point.
Africa
October 30, 2013. Laura Watermeyer ,”Africa: Costs Keep Cancer Drugs Out of Developing Countries,” AllAfrica.
February 4, 2011. Emilie Filou, “In Africa, cancer is a burden that can no longer be ignored,” The Guardian.
Uganda
December 1, 2011. Felix Basiime, “The cancer is curable but drugs are expensive,” The Daily Monitor.
Zimbabwe
October 10, 2014. Wongai Zhzangazha, “Zimbabwe: Cancer Treatment Remains Out of Reach,” AllAfrica.
Nigeria
September 22, 2013. Sola Ogundipe, “Nigerians pay for cancer treatment with their lives,” Vanguard.
Kenya
November 10, 2011. “Kenya: Hope for Cancer Patients,” Human Rights Watch.
October 10, 2013. Sandra Chao, “Cancer groups push for tax cut on drug imports,” Business Daily Africa.
February 3, 2013. Evelyn Situma, “High cost of cancer treatment burdens patients,” Business Daily Africa.
Asia
India
October 1, 2014. Iftikhar Gilani, “Cancer drug price goes up from Rs 8,000 to Rs 1.08 lakh,” DNA.
September 24, 2014. Rupali Mukherjee, “Government curbs power of regulator to cap HIV, cancer drug prices,” The Times of India.
December 29, 2013. Gardiner Harris, “India’s Efforts to Aid Poor Worry Drug Makers,” The New York Times.
November 26, 2013. Anju Ghangurd, “First biosimilar Herceptin approved in India amid calls for genuinely affordable pricing,” SCRIP Intelligence.
August 12, 2013. Ajay Mahal et al, “The Economic Burden of Cancers on Indian Households,” PLOS one.
May 31, 2013. Rema Nagarajan, “Doctors call cancer drug pricing profiteering, call for price cuts,” The Times of India.
February 17, 2013. E. Kumar Sharma, “Killer Costs,” Business Today IN.
May 4, 2012. Rumman Ahmed, “India’s Cipla Cuts Cancer Drug Prices by 75%,” The Wall Street Journal.
March 14, 2012. G. Ananthakrishnan, “A historic move to make drugs affordable,” The Hindu
June 5, 2003. Stephanie Strom and Matt Fleischer-Black, “Drug Maker’s Vow to Donate Cancer Medicine Falls Short,” The New York Times.
Singapore
May 24, 2013. Dr. Ong Sin Tiong, “What would you pay for another year of life?” The Real Singapore.
May 12, 2011. Deborah Choo, “Why are cancer treatments not subsidized by the government?” The Online Citizen.
Indonesia
August 3, 2012. Uyung Pramudiarja, “YKI: Biaya Pengobatan Kanker Rata-rata Rp 100 Juta/Bulan (ICF: Cancer care costs average USD $100 million/month),” DetikHealth.
December 17, 2011. Elly Burhaini Faizal, “Govt to study full cost of cancer,” the Jakarta Post.
Thailand
July 2009. “Assessing the implication of Thailand’s government use licenses issued in 2006-2008,” Health Intervention and Technology Assessment Program.
South America
Brazil
September 22, 2014. Paul Yokota, “Remédios caros e os genéricos (Expensive medicines and generics),” Carta Capital.
“MEDICAMENTO DE ALTO CUSTO CONTRA O CÂNCER PODE TER GENÉRICO NACIONAL (High cost of medicine for cancer may become national generic),” INCT de Fármacos e Medicamentos.